26-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “Bladder Cancer Therapeutics Market By Cancer Type (Transitional Cell Bladder Cancer, Superficial Bladder Cancer, Invasive Bladder Cancer, Squamous Cell Bladder Cancer, and Other Rare Types), and by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global bladder cancer therapeutics market in 2019 was approximately USD 3,700 million. The market is expected to grow above a CAGR of 4.1% and is anticipated to reach over USD 4,930 million by 2026.
Bladder cancer is caused by the rapid, unchecked growth of abnormal urinary bladder cells. Those cancer cells spread through the lining of the bladder's muscle wall. More cancer cells grow to form a tumor that may spread to other parts of the body as well. Many treatments have emerged to treat bladder cancers, raising demand for bladder cancer therapy. Factors such as technical advances, creative technologies, specialized health care infrastructure, growing people's awareness of cancer therapies and rising health care spending will drive the global demand for bladder cancer therapies.
Browse the full “Bladder Cancer Therapeutics Market By Cancer Type (Transitional Cell Bladder Cancer, Superficial Bladder Cancer, Invasive Bladder Cancer, Squamous Cell Bladder Cancer, and Other Rare Types), and by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/bladder-cancer-therapeutics-market-by-cancer-type-transitional-947
The high cost of bladder cancer therapies and the asymptomatic nature of the disease can limit the market growth. But factors such as the growing prevalence of targeted biologics, the launch of new drugs and the acceptance of effective diagnostic tools that increase demand for the global therapeutic market for bladder cancer.
The global bladder cancer therapeutics market has been segmented on the basis of cancer type and treatment. On the basis of cancer type segment, the target market is segmented into transitional cell bladder cancer, superficial bladder cancer, invasive bladder cancer, squamous cell bladder cancer, and other rare types. Also, on the basis of the treatment segment, the global market is segmented into chemotherapy, immunotherapy, radiation therapy, and others.
North America continues to dominate the global market for the target market, owing to the presence of key operating players in the target market. Also, the availability of advanced healthcare facilities in the countries if this region is also propelling growth of the target market in this region. The Asia Pacific market is expected to rise at a faster rate of growth over the forecast year as a result of increased awareness among people, increased investment in R&D, the use of skilled labor to produce products and increased investment by the pharmaceutical industry. Also, the market in the Middle East and Africa is expected to show lucrative growth opportunities in the countries of this region.
Top key players operating in the market are Pfizer Inc., Novartis AG, AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, Celgene Corporation, Merck & Co., Sanofi S.A., and GlaxoSmithKline Plc. among others. The key players operating in the global bladder cancer therapeutics market are focusing on organic as well as inorganic growth strategies to get a competitive edge in the global market. Innovations and the launch of advanced products are creating opportunities in the target market.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 3,700 million |
Projected Market Size in 2026 |
USD 4,930 million |
CAGR Growth Rate |
4.1% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Pfizer Inc., Novartis AG, AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, Celgene Corporation, Merck & Co., Sanofi S.A., and GlaxoSmithKline Plc. |
Key Segment |
By Type, By Treatment, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
This report segments the Bladder Cancer Therapeutics market as follows:
Global Bladder Cancer Therapeutics Market: Cancer Type segment Analysis
- Transitional Cell Bladder Cancer
- Superficial Bladder Cancer
- Invasive Bladder Cancer
- Squamous Cell Bladder Cancer
- Other Rare Types
Global Bladder Cancer Therapeutics Market: Treatment Segment Analysis
- Chemotherapy
- Immunotherapy
- Radiation Therapy
- Others
Global Bladder Cancer Therapeutics Market Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
